Atlas Trials

MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors

Clinical trial NCT05076760 · RECRUITING

Trial details

NCT number
NCT05076760
Sponsor
Memgen, Inc.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Solid TumorAdvanced CancerMetastatic CancerNon Small Cell Lung CancerCutaneous Squamous Cell CarcinomaMerkel Cell CarcinomaMelanomaPancreatic CancerTriple Negative Breast CancerHead and Neck Cancer
Start date
2022-04-21
Primary completion
2027-02-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.